Fabi, Adriano
Milosavljevic, Stefan
Lang, Claudia C. V.
Guillet, Carole
Schmid-Grendelmeier, Peter
Funding for this research was provided by:
University of Zurich
Article History
Received: 5 October 2023
Accepted: 13 November 2023
First Online: 12 December 2023
Declarations
:
: P. Schmid-Grendelmeier has received honoraria for advisory boards and speaker fees from Novartis. A. Fabi, S. Milosavljevic, C.C.V. Lang and C. Guillet declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the institute’s committee on human research (Kantonale Ethik-Kommission Zürich, BASEC Nr.: 2021-01715). Informed consent was obtained from all individual participants included in the study.